Q4 2024 Earnings Call Transcript January 23, 2025 Texas Instruments Incorporated beats earnings expectations. Reported EPS is $1.3, expectations were $1.2. Dave Pahl: Welcome to the Texas Instruments Fourth Quarter 2024 Earnings Conference Call.

Texas Instruments announced fourth-quarter earnings above expectations, but highlighted challenges with declining revenues year-over-year.

Texas Instruments (NASDAQ:TXN) received a reiterated Buy rating and a $250.00 price target from Rosenblatt analysts ahead of its fourth-quarter earnings report, which is scheduled for release after the market closes on January 23,

We recently compiled a list of the Jim Cramer Discussed These 10 Stocks, AI Power Demand & Healthcare. In this article, we are going to take a look at where Texas Instruments Incorporated (NASDAQ:TXN) stands against the other stocks.

It looks like Texas Instruments Incorporated (NASDAQ:TXN) is about to go ex-dividend in the next 4 days. The ex-dividend date is one business day before a company's record date, which is the date on which the company determines which shareholders are entitled to receive a dividend.

We recently published a list of Kevin O’Leary’s Stock Portfolio: 15 Stock Picks for 2025. In this article, we are going to take a look at where Texas Instruments Incorporated (NASDAQ:TXN) stands against other Kevin O’Leary’s stock picks for 2025.

High-yielding Texas Instruments (NASDAQ: TXN) stock is nearing a bottom and is poised to rebound strongly in 2025. The company’s business contracted in 2024 but is reverting to growth in 2025, and the long-term outlook is robust.

Analog chip manufacturer Texas Instruments (NASDAQ:TXN) reported Q4 CY2024 results , but sales fell by 1.7% year on year to $4.01 billion. Guidance for next quarter’s revenue was better than expected at $3.

Shares of Texas Instruments Inc and Verizon Communications Inc have been in a sharp downtrend in recent months, but the sell-off has made neither of these any more attractive to own. In fact, Michael Landsberg dubbed both a “value trap” in a recent interview with CNBC.

Healthcare Triangle, Inc., a healthcare information technology company, focuses on developing solutions in the sectors of cloud services, data science, and professional and managed services for ...

The federal funding freeze put forth by the Trump administration has put the CHIPs Act grants to semiconductor companies in "limbo," even if they are "likely to survive," Bank of America said. "Over $33.

Semiconductor equipment maker Lam Research (NASDAQ:LRCX) will be reporting results tomorrow after market hours. Here’s what to expect. Lam Research beat analysts’ revenue expectations by 2.7% last quarter,